207
Participants
Start Date
February 28, 2009
Primary Completion Date
April 30, 2009
Study Completion Date
July 31, 2009
Azelaic acid (Finacea, BAY39-6251)
Participants received topical azelaic acid gel 15% twice daily for 12 weeks
Metronidazole (Metrogel)
Participants received topical metronidazole 1% gel once daily for 12 weeks
Doxycycline (Oracea)
Participants received systemic doxycycline 40 mg once daily for 12 week
Stony Brook
Norfolk
West Palm Beach
Birmingham
Mason
Warren
Fridley
Dallas
Houston
San Antonio
Austin
Denver
Salt Lake City
Albuquerque
Henderson
Portland
Boston
Lead Sponsor
Collaborators (1)
Bayer
INDUSTRY
LEO Pharma
INDUSTRY